In summary, aspirin inhibits tumor progression and enhances the CDDP sensitivity of EOC cells through p53 acetylation and subsequent activation of p53 target genes that regulate tumor migration, proliferation, and chemoresistance. Here, TP53 is linked to neoplasm.